Correlates of tobacco product reuptake and relapse among youth and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).
Adolescent
Adult
Age Factors
Child
Cohort Studies
Female
Follow-Up Studies
Humans
Longitudinal Studies
Male
Middle Aged
Recurrence
Sex Factors
Smoking Cessation
/ statistics & numerical data
Time Factors
Tobacco Products
/ statistics & numerical data
Tobacco Use
/ epidemiology
Tobacco Use Disorder
/ epidemiology
United States
/ epidemiology
Young Adult
electronic nicotine delivery devices
non-cigarette tobacco products
surveillance and monitoring
Journal
Tobacco control
ISSN: 1468-3318
Titre abrégé: Tob Control
Pays: England
ID NLM: 9209612
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
24
01
2020
revised:
31
01
2020
accepted:
03
02
2020
entrez:
24
4
2020
pubmed:
24
4
2020
medline:
3
6
2021
Statut:
ppublish
Résumé
This study examines sociodemographic and tobacco use correlates of reuptake and relapse to tobacco use across a variety of tobacco products (cigarettes, electronic nicotine delivery systems, cigars, hookah and smokeless tobacco) among the US population. Data were drawn from the first three waves (2013-2016) of the Population Assessment of Tobacco and Health Study, a nationally representative, longitudinal cohort study of US youth (ages 12-17) and adults (ages 18+). Reuptake (past 30-day use among previous tobacco users) and relapse (current use among former established users; adults only) were examined among previous users of at least one type of tobacco product at Wave 1 (W1) or Wave 2 (W2) (n=19 120 adults, n=3039 youth). Generalised estimating equations were used to evaluate the association between demographic and tobacco use characteristics at baseline, with reuptake/relapse at follow-up, over two 1-year periods (W1-W2 and W2-Wave 3). Any tobacco product reuptake occurred in 7.8% of adult previous users and 30.3% of youth previous users. Correlates of any tobacco reuptake included being male, non-Hispanic black and bisexual in adults, but race and sexual orientation were not consistent findings in youth. Among recent former users, relapse rates were greater (32.9%). Shorter time since last use and greater levels of tobacco dependence showed the strongest association with any tobacco relapse. Continued clinical and public health efforts to provide adults with tools to cope with tobacco dependence symptoms, especially within the first year or two after quitting, could help prevent relapse.
Identifiants
pubmed: 32321855
pii: tobaccocontrol-2020-055660
doi: 10.1136/tobaccocontrol-2020-055660
pmc: PMC7517708
mid: NIHMS1604101
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
s216-s226Subventions
Organisme : NIDA NIH HHS
ID : HHSN271201100027C
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: WMC reports long-term stock holdings in General Electric Company, 3M Company, and Pfizer Incorporated, unrelated to this manuscript. No financial disclosures were reported by the other authors of this paper.
Références
Am J Public Health. 2011 Oct;101(10):1955-62
pubmed: 21852638
Vital Health Stat 2. 1969 Jan;(31):1-24
pubmed: 5306564
MMWR Morb Mortal Wkly Rep. 2015 Apr 17;64(14):381-5
pubmed: 25879896
Arch Gen Psychiatry. 1986 Mar;43(3):289-94
pubmed: 3954551
PLoS One. 2017 Feb 9;12(2):e0171808
pubmed: 28182748
Tob Control. 1997;6 Suppl 2:S57-62
pubmed: 9583654
J Adolesc Health. 2016 Feb;58(2):181-5
pubmed: 26598059
Am Psychol. 1986 Jul;41(7):765-82
pubmed: 3527003
Am J Psychiatry. 1993 Oct;150(10):1546-7
pubmed: 8379564
Nicotine Tob Res. 2008 Aug;10(8):1283-91
pubmed: 18686175
Health Psychol. 2008 Nov;27(6):811-8
pubmed: 19025277
Public Health Rep. 2019 Sep/Oct;134(5):528-536
pubmed: 31419184
Tob Induc Dis. 2017 Mar 14;15:17
pubmed: 28316562
JAMA. 2018 Oct 2;320(13):1379-1380
pubmed: 30285167
Tob Control. 2020 May;29(Suppl 3):s163-s169
pubmed: 32321850
Ann N Y Acad Sci. 2017 Apr;1394(1):5-30
pubmed: 26774031
Am J Prev Med. 2015 Jun;48(6):742-6
pubmed: 25890683
BMC Public Health. 2016 Aug 18;16(1):814
pubmed: 27538489
Nicotine Tob Res. 2019 Sep 19;21(10):1423-1428
pubmed: 30239953
Tob Control. 2020 May;29(Suppl 3):s155-s162
pubmed: 32321849
Clin Psychol Rev. 2006 Mar;26(2):196-215
pubmed: 16352382
J Abnorm Psychol. 2009 May;118(2):348-59
pubmed: 19413409
J Adolesc Health. 2014 Jan;54(1):47-53
pubmed: 24060573
Health Psychol. 1993 Nov;12(6):443-50
pubmed: 8293727
N Engl J Med. 2010 Jun 17;362(24):2295-303
pubmed: 20554984
MMWR Morb Mortal Wkly Rep. 2014 Jun 27;63(25):542-7
pubmed: 24964880
Circulation. 2010 Apr 6;121(13):1518-22
pubmed: 20368531
Addict Behav. 2002 Mar-Apr;27(2):241-50
pubmed: 11817765
Tob Control. 2017 Jul;26(4):371-378
pubmed: 27507901
Nicotine Tob Res. 2016 May;18(5):834-41
pubmed: 26385927
Addict Behav. 2014 Jan;39(1):101-6
pubmed: 24172753
Nicotine Tob Res. 2004 Dec;6 Suppl 3:S363-9
pubmed: 15799599
Nicotine Tob Res. 2015 Feb;17(2):219-27
pubmed: 25239961
Nicotine Tob Res. 2013 Nov;15(11):1822-31
pubmed: 23680918
Addiction. 2011 Dec;106(12):2110-21
pubmed: 21752135
J Adolesc Health. 2014 Jan;54(1):54-60.e9
pubmed: 24074604
Public Health. 2016 Aug;137:124-30
pubmed: 27003670
Health Psychol. 2000 May;19(3):223-31
pubmed: 10868766
Tob Control. 2020 May;29(Suppl 3):s139-s146
pubmed: 32321847
LGBT Health. 2018 Jan;5(1):33-44
pubmed: 29324177
Health Psychol. 1986;5 Suppl:3-11
pubmed: 3582323
Addict Behav. 2016 Sep;60:154-9
pubmed: 27155241
Tob Control. 2020 May;29(Suppl 3):s191-s202
pubmed: 32321853
Health Psychol. 2000 Jan;19(1S):17-31
pubmed: 10709945
J Abnorm Psychol. 1988 May;97(2):133-52
pubmed: 3290304
Addict Behav. 2015 Dec;51:113-9
pubmed: 26253939
Addict Behav. 2009 Apr;34(4):365-73
pubmed: 19097706
N Engl J Med. 2017 Jan 26;376(4):342-353
pubmed: 28121512
Tob Control. 2020 May;29(Suppl 3):s170-s177
pubmed: 32321851
Tob Control. 2020 May;29(Suppl 3):s147-s154
pubmed: 32321848
Drug Alcohol Depend. 2017 Sep 1;178:257-266
pubmed: 28675817